Trends in Cardiovascular Medicine
Volume 15, Issue 1 , Pages 24-34 , January 2005

Signaling Mechanisms in Cerebral Vasospasm

  • Shigeru Nishizawa
    • ,
  • Ismail Laher

      Affiliations

    • Corresponding Author InformationAddress correspondence to: I. Laher, Department of Pharmacology and Therapeutics, Faculty of Medicine, University of British Columbia, 2176 Health Sciences Mall, Vancouver, BC, Canada V6T 1Z3, Canada. Tel.: (+1) 604-822-5882; fax: (+1) 604-224-5142.

References 

  1. Aihara Y, Jahromi BS, Yassari R, et al. Molecular profile of vascular ion channels after experimental subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2004;24:75–83
  2. Chen D, Nishizawa S, Yokota N, et al. High-dose methylprednisolone prevents vasospasm after subarachnoid hemorrhage through inhibition of protein kinase C activation. Neurol Res. 2002;24:215–222
  3. Coyne TJ, Montanera WJ, Macdonald RL, Wallance MC. Percutaneous transluminal angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Can J Surg. 1994;37:391–396
  4. Dietrich H, Dacey R. Molecular keys to the problems of cerebral vasospasm. Neurosurgery. 2000;46:517–530
  5. Dorsch NWC. Therapeutic approaches to vasospasm in subarachnoid hemorrhage. Curr Opin Cell Care. 2002;8:128–133
  6. Feigin VL, Rinkel GJ, Algra A, et al. Calcium antagonists in patients with aneurysmal subarachnoid hemorrhage: a systemic review. Neurology. 1998;50:876–883
  7. Fisher M, Grotta J. New uses for calcium channel blockers. Therapeutic implications. Drugs. 1993;46:961–975
  8. Harder DR, Dernbach P, Waters A. Possible cellular mechanism for cerebral vasospasm after experimental subarachnoid hemorrhage in the dog. J Clin Invest. 1987;80:875–880
  9. Hino A, Tokuyama Y, Kobayashi M, et al. Increased expression of endothelin B receptor mRNA following subarachnoid hemorrhage in monkeys. J Cereb Blood Flow Metab. 1996;16:678–679
  10. Honma Y, Fuiwara T, Irie K, et al. Morphological changes in human cerebral arteries after percutaneous transluminal angioplasty for vasospasm caused by subarachnoid hemorrhage. Neurosurgery. 1995;36:1073–1081
  11. Hu E, Lee D. Rho-kinase inhibitors as potential therapeutic agents for cardiovascular diseases. Curr Opin Invest Drugs. 2003;4:1065–1075
  12. Ishiguro M, Puryear CB, Bisson E, et al. Enhanced myogenic tone in cerebral arteries from a rabbit model of subarachnoid hemorrhage. Am J Phsyiol. 2002;283:H2217–H2225
  13. Jewell RP, Saundry CM, Bonev AD, et al. Inhibition of Ca++ sparks by oxyhemoglobin in rabbit cerebral arteries. J Neurosurg. 2004;100:295–302
  14. Kassell NF, Helm G, Simmons N, et al. Treatment of cerebral vasospasm with intra-arterial papaverine. J Neurosurg. 1992;77:848–852
  15. Katoh H, Shima K, Shimazu A, et al. Clinical evaluation of the effect of percutaneous transluminal angioplasty and intra-arterial papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. Neurol Res. 1999;21:195–203
  16. Kazan S. Effects of intra-arterial papaverine on the chronic period of cerebral arterial vasospasm in rats. Acta Neurol Scand. 1998;98:354–359
  17. Kehl F, Camj-Sapunar L, Maier KG, et al. 20-HETE contributes to the acute fall in cerebral blood flow after subarachnoid hemorrhage in rats. Am J Physiol. 2002;282:H1556–H1565
  18. Koide M, Nishizawa S, Ohta S, et al. Chronological changes of the contractile mechanism in prolonged vasospasm after subarachnoid hemorrhage : from protein kinase C to protein tyrosine kinase. Neurosurgery. 2002;51:1468–1476
  19. Kusaka G, Kimura H, Kusaka I, et al. Contribution of Src tyrosine kinase to cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg. 2003;99:383–390
  20. Laher I, Zhang JH. Protein kinase C and cerebral vasospasm. J Cereb Blood Flow Metab. 2001;21:887–906
  21. Laporte R, Hui A, Laher I. Pharmacological modulation of sarcoplasmic reticulum function in smooth muscle. Pharmacol Rev. 2004;56:439–513
  22. Liu JK, Tenner MS, Gottfried ON, et al. Efficacy of multiple intraarterial papaverine infusions for improvement in cerebral circulation time in patients with recurrent vasopasm. J Neurosurg. 2004;100:414–421
  23. Lyons MA, Shukla R, Zhang K, et al. Increase of metabolic activity and disruption of normal contractile protein disruption by bilirubin oxidation products in vascular smooth muscle cells. J Neurosurg. 2004;100:505–511
  24. Meyer FB. Calcium antagonists and vasospasm. Neurosurg Clin N Am. 1990;1:367–376
  25. Milburn JM, Moran CJ, Cross DT, et al. Increase in diameter of vasospastic intracranial arteries by intra-aterial papaverine administration. J Neurosurg. 1998;88:38–42
  26. Nishizawa S, Peterson JW, Shimoyama I, et al. Therapeutic effect of a new immunosupressant. FK-506, on vasospasm after subarachnoid hemorrhage. Neurosurgery. 1993;32:986–991
  27. Nishizawa S, Yamamoto S, Yokoyama T, et al. Chronological changes of arterial diameter, cGMP and protein kinase C in the development of vasospasm. Stroke. 1995;26:1916–1921
  28. Nishizawa S, Obara K, Nakayama K, et al. Protein kinase C α and δ are involved in the development of vasospasm after subarachnoid hemorrhage. Eur J Pharmacol. 2000;398:113–119
  29. Nishizawa S, Chen D, Yokoyama T, et al. Endothelin-1 initiates the development of vasospasm after subarachnoid haemorrhage through protein kinase C activation, but does not contribute to prolonged vasospasm. Acta Neurochirur. 2000;142:1409–1415
  30. Nishizawa S, Obara K, Koide M, et al. Attenuation of canine cerebral vasospasm after subarachnoid hemorrhage by protein kinase C inhibitors despite augmented phosphorylation of myosin light chain. J Vasc Res. 2003;40:168–179
  31. Peterson JW, Kwun BD, Hackett JD, Zervas NT. The role of inflammation in experimental cerebral vasospasm. J Neurosurg. 1990;72:767–774
  32. Peterson JW, Roussos L, Kwun BD, et al. Evidence of the role of hemolysis in experimental cerebral vasospasm. J Neurosurg. 1990;72:775–781
  33. Peterson JW, Nishizawa S, Hackett JD, et al. Cyclosporine A reduces vasospasm after subarachnoid hemorrhage in dogs. Stroke. 1990;21:133–137
  34. Polin RS, Coenen VA, Hansen CA, et al. Efficacy of transluminal angioplasty for the management of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2000;92:284–290
  35. Pyne Gj, Cadoux-Hudson TA, Clark JF. The presence of an extractable substance in the CSF of humans with cerebral vasospasm after subarachnoid haemorrhage that correlates with phosphatase inhibition. Biochim Biophys Acta. 2000;147:283–290
  36. Sun H, Kanamaru K, Ito M, et al. Myosin light chain phosphorylation and contractile proteins in a canine two-hemorrhage model of subarachnoid hemorrhage. Stroke. 1998;29:2149–2154
  37. Takuwa Y, Matsui T, Abe Y, et al. Alterations in protein kinase C activity and membrane lipid metabolism in cerebral vasospasm after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 1993;13:409–415
  38. Treggiari MM, Walder B, Suer PM, et al. Systemic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemmorrhage. J Neurosurg. 2003;98:978–984
  39. Wadworth AN, McTavish D. Nimodipine. A review of its pharmacological properties, and therapeutic efficacy in cerebral disorders. Drugs Aging. 1992;2:262–286
  40. Wellman GC, Nathan DJ, Saundry CM, et al. Ca2+ sparks and their function in human cerebral arteries. Stroke. 2002;33:802–808
  41. Yamada T, Tanaka Y, Fujimoto K, et al. Relationship between cytosolic Ca2+ level and contractile tension in canine basilar artery of chronic vasospasm. Neurosurgery. 1994;34:496–504
  42. Yoon S, Sherman JD, Zuccarello M, Rapoport RM. Vasospasm following subarachnoid hemorrhage: evidence against functional upregulation of Rho kinase constrictor pathway. Neurol Res. 2002;24:392–394
  43. Yu M, Camj-Sapunar L, Kehl F, et al. Effects of a 20-HETE antagonists and agonists on cerebral vascular tone. Eur J Pharmacol. 2004;486:297–306
  44. Zimmermann M. Endothelin in cerebral vasospasm. J Neurosurg Sci. 1997;41:139–151
  45. Zimmermann M, Seifert V. Endothelin and subarachnoid hemorrhage. Neurosurgery. 1998;43:836–876
  46. Zubkov YN, Alexander LF, Smith RR, et al. Angioplasty of vasospasm: is it reasonable?. Neurol Res. 1994;16:9–11

PII: S1050-1738(04)00183-5

doi: 10.1016/j.tcm.2004.12.002

Trends in Cardiovascular Medicine
Volume 15, Issue 1 , Pages 24-34 , January 2005

Article Tools

* Image Usage & Resolution